against Tcell receptor (TcR)-CD3 complex

Industry

CPC
A61K51/1042

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

AHUMAN NECESSITIES A61Medical science A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo

Current Industry

A61K51/1042against Tcell receptor (TcR)-CD3 complex

Industries

Patents Grantslast 30 patents

Information Patent Grant
Use of bispecific antigen-binding molecules that bind MUC16 and CD3...
- Patent number 12,091,460
- Issue date Sep 17, 2024
- REGENERON PHARMACEUTICALS, INC.
- Jessica R. Kirshner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Feeder cell and method for growing gamma delta T cells by using same
- Patent number 12,077,779
- Issue date Sep 3, 2024
- The Catholic University of Korea Industry-Academic Cooperation Foundation
- Tai Gyu Kim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multispecific antibodies that target HIV GP120 and CD3
- Patent number 11,597,759
- Issue date Mar 7, 2023
- Gilead Sciences, Inc.
- Tomas Cihlar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multiple antigen binding molecular fusion, pharmaceutical compositi...
- Patent number 11,400,157
- Issue date Aug 2, 2022
- CHUGAI SEIYAKU KABUSHIKI KAISHA
- Tomoyuki Igawa
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-ROR1 antibodies
- Patent number 11,155,615
- Issue date Oct 26, 2021
- Eureka Therapeutics, Inc.
- Brian Wong
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Drug-conjugated bi-specific antigen-binding constructs
- Patent number 11,147,886
- Issue date Oct 19, 2021
- ZYMEWORKS INC.
- Gordon Yiu Kon Ng
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Multispecific antibodies that target HIV GP120 and CD3
- Patent number 10,882,907
- Issue date Jan 5, 2021
- Gilead Sciences, Inc.
- Doug Rehder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multispecific antibodies that target HIV GP120 and CD3
- Patent number 10,836,825
- Issue date Nov 17, 2020
- Gilead Sciences, Inc.
- Doug Rehder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Alpha or beta emitters attached to fragments in radioimmunotherapy
- Patent number 7,220,399
- Issue date May 22, 2007
- Center for Molecular Medicine and Immunology
- David M. Goldenberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Alpha or beta emitters attached to fragments in radioimmunotherapy
- Patent number 6,667,024
- Issue date Dec 23, 2003
- Center for Molecular Medicine and Immunology
- David M. Goldenberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal antibody therapy
- Patent number 4,731,244
- Issue date Mar 15, 1988
- Ortho Pharmaceutical Corporation
- Mary A. Talle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
THERAPEUTIC ANTIBODIES
- Publication number 20240209086
- Publication date Jun 27, 2024
- PETMEDIX LTD
- Meng Amy LI
- G01 - MEASURING TESTING
Information Patent Application
METHODS OF IMAGING USING MULTIPLE IMAGING AGENTS
- Publication number 20230211024
- Publication date Jul 6, 2023
- ImaginAb, Inc.
- Alessandro Mascioni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTIPLE ANTIGEN BINDING MOLECULAR FUSION, PHARMACEUTICAL COMPOSITI...
- Publication number 20220401557
- Publication date Dec 22, 2022
- Chugai SeiYaku Kabushiki Kaisha
- Tomoyuki IGAWA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS OF IMMUNODEPLETION FOR THE TREATMENT OF MA...
- Publication number 20220202967
- Publication date Jun 30, 2022
- ACTINIUM PHARMACEUTICALS, INC.
- Dale Ludwig
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND MUC16 AND CD3...
- Publication number 20200399371
- Publication date Dec 24, 2020
- Regeneron Pharmaceuticals, Inc.
- Jessica R. Kirshner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND PSMA AND CD3...
- Publication number 20200399372
- Publication date Dec 24, 2020
- Regeneron Pharmaceuticals, Inc.
- Jessica R. Kirshner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTISPECIFIC ANTIBODIES THAT TARGET HIV GP120 AND CD3
- Publication number 20200377592
- Publication date Dec 3, 2020
- GILEAD SCIENCES, INC.
- Tomas Cihlar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CAMEL DERIVED POLYPEPTIDES BINDING HUMAN CD3, IDENTIFIED USING A NO...
- Publication number 20190218290
- Publication date Jul 18, 2019
- ANTI-DOPING LAB QATAR
- Pasquale VITO
- G01 - MEASURING TESTING
Information Patent Application
MULTISPECIFIC ANTIBODIES THAT TARGET HIV GP120 AND CD3
- Publication number 20180371086
- Publication date Dec 27, 2018
- GILEAD SCIENCES, INC.
- Tomas Cihlar
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DRUG-CONJUGATED BI-SPECIFIC ANTIGEN-BINDING CONSTRUCTS
- Publication number 20180193477
- Publication date Jul 12, 2018
- Zymeworks Inc.
- Gordon Yiu Kon Ng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-ROR1 ANTIBODIES
- Publication number 20180142016
- Publication date May 24, 2018
- Five Prime Therapeutics, Inc.
- Brian WONG
- G01 - MEASURING TESTING
Information Patent Application
Alpha or beta emitters attached to fragments in radioimmunotherapy
- Publication number 20040180001
- Publication date Sep 16, 2004
- Center for Molecular Medicine and Immunology
- David M. Goldenberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

against Tcell receptor (TcR)-CD3 complex

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Use of bispecific antigen-binding molecules that bind MUC16 and CD3...

Feeder cell and method for growing gamma delta T cells by using same

Multispecific antibodies that target HIV GP120 and CD3

Multiple antigen binding molecular fusion, pharmaceutical compositi...

Anti-ROR1 antibodies

Drug-conjugated bi-specific antigen-binding constructs

Multispecific antibodies that target HIV GP120 and CD3

Multispecific antibodies that target HIV GP120 and CD3

Alpha or beta emitters attached to fragments in radioimmunotherapy

Alpha or beta emitters attached to fragments in radioimmunotherapy

Monoclonal antibody therapy

Patents Applicationslast 30 patents

THERAPEUTIC ANTIBODIES

METHODS OF IMAGING USING MULTIPLE IMAGING AGENTS

MULTIPLE ANTIGEN BINDING MOLECULAR FUSION, PHARMACEUTICAL COMPOSITI...

COMPOSITIONS AND METHODS OF IMMUNODEPLETION FOR THE TREATMENT OF MA...

USE OF BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND MUC16 AND CD3...

USE OF BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND PSMA AND CD3...

MULTISPECIFIC ANTIBODIES THAT TARGET HIV GP120 AND CD3

CAMEL DERIVED POLYPEPTIDES BINDING HUMAN CD3, IDENTIFIED USING A NO...

MULTISPECIFIC ANTIBODIES THAT TARGET HIV GP120 AND CD3

DRUG-CONJUGATED BI-SPECIFIC ANTIGEN-BINDING CONSTRUCTS

ANTI-ROR1 ANTIBODIES

Alpha or beta emitters attached to fragments in radioimmunotherapy